Total Funding
23
41
Total FundingPost-IPO Equity raised
Growth Score
1 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
129248
Arena Pharmaceuticals is focused on delivering solutions for cardiovascular, central nervous system, inflammatory and metabolic diseases.
- John Grundy: Vice President of Nonclinical Development & Clinical PharmacologyPast Role: DTx Pharma, Member Board Of Directors and Co-Founder
- Suzanne Zoumaras: EVP & Chief Human Capital OfficerPast Role: Teradata, EVP & Chief Human Capital Officer
Pfizer
About the Company
Clinical-stage biotech focused on cardiovascular, central nervous system, inflammatory and metabolic diseases. Their leading drug candidate is lorcaserin hydrochloride, which recently received positive data from a clinical trial. They are headquartered in San Diego, CA.
